Business
Kovo+ Holdings Inc. Announces LIFE Offering, Concurrent Private Placement & Warrant Extension
Vancouver, British Columbia--(Newsfile Corp. - March 19, 2025) - Kovo+ Holdings Inc. (TSXV: KOVO)...
About this update from Kovo+ Holdings Inc
[{"type":"text","content":"Kovo+ Holdings Inc. Announces LIFE Offering, Concurrent Private Placement & Warrant ExtensionVancouver, British Columbia--(Newsfile Corp. - March 19, 2025) - Kovo+ Holdings Inc. (TSXV: KOVO) (formerly Kovo HealthTech Corporation) (\"Kovo\" or the \"Company\") is pleased to announce a best efforts private placement (the \"LIFE Offering\") of up to 28,000,000 common shares (the \"Offered Shares\") of the Company at a price of $0.05 per Offered Share for aggregate gross proceeds of up to $1,400,000.Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 - Prospectus Exemptions (\"NI 45-106\"), the LIFE Offering is being made to purchasers' resident in all provinces of Canada, except Quebec, Newfoundland and Labrador, and Prince Edward Island pursuant to the listed issuer financing exemption under Part 5A of NI 45-106 (the \"Listed Issuer Financing Exemption\"). The securities issued pursuant to the Listed Issuer Financing Exemption will not be subject to a hold period in accordance with applicable Canadian securities laws.Further to its news release dated December 12, 2024, Kovo previously entered into an agreement with FrontFundr Financial Services Inc. (the \"Agent\") to act as sole agent in connection with the LIFE Offering. The Agent shall receive a cash commission equal to 7.0% of the gross proceeds of the LIFE Offering, other than with respect to sales to purchasers on the president's list, if any, for which the Agent will receive a cash fee of 1.0% of the number of Offered Shares issued to purchasers on the president's list.An offering document related to the LIFE Offering (the \"Offering Document\") will be available under the Company's profile at www.sedarplus.ca and on the Company's website at www.kovoplus.com. Prospective purchasers should read the Offering Document before making an investment decision.In addition to the LIFE Offering, the Company intends to issue up to 685,714,286 units (each, a \"Unit\") on a non-brokered private placement basis for gross proceeds of $34,285,714 (the \"Concurrent Offering\" and together with the LIFE Offering, the \"Offerings\") at a price of $0.05 per Unit. Each Unit will consist of (i) one common share (each, a \"Concurrent Offered Share\") of the Company and (ii) one-half of one non-transferable common share purchase warra...